A life-sciences district
Lilly Facility

- Programme
- Mixed-use
- Size
- 80,000 m²
- Location
- Katwijk
- Status
- In development
The facility represents an investment of €2.6 billion, comprises more than 80,000 m² of laboratory, office, and production buildings, and will become part of the Leiden Bio Science Park, a life-sciences district where living meets nature.
With an investment of €2.6 billion, this is one of the largest foreign corporate investments in the Netherlands of the past few decades. The new production facility comprises approximately 80,000 m² of gross floor area and is used for the production of medicines in tablet form, including for the treatment of diabetes, obesity, and other cardiometabolic conditions.

€2.6B

Development
80,000 m²
A life-sciences district
The facility will create 500 jobs, for engineers, scientists, operational staff and laboratory technicians, and 1,500 jobs in construction. In Katwijk, Lilly will produce medicines for patients worldwide in the fields of cardiometabolic health (including diabetes and obesity), neuroscience, oncology and immunology. The facility will make use of advanced production technologies, including dock-to-dock automation and paperless manufacturing.
For RED Company the project is a logical next step in the life science sector, after an earlier collaboration with Johnson & Johnson, for which it realised an office and laboratory building of 13,500 m² at the Leiden Bio Science Park.
“We are extremely proud that, with a combination of entrepreneurship and constructive collaboration with the various authorities, we have helped ensure that Eli Lilly chose the Netherlands within Europe. For our firm, after ten years, this is the perfect moment to carry out an international project of this order.”
Nanne de Ru
Founding Partner
Entrepreneurial spirit
The development of the new research and production facility is a joint effort of Eli Lilly, the national government, the province of Zuid-Holland, the municipality of Katwijk, the Leiden Bio Science Park, the Netherlands Foreign Investment Agency and RED Company.

If you have specific questions about this project, please reach out.
Team
- Partners
- Eli Lilly and Company, CBRE (adviseur Eli Lilly), ING, RED Bouw, Netherlands Enterprise Agency, Netherlands Foreign Investment Agency, Provincie Zuid-Holland, Gemeente Katwijk, Leiden Bio Science Park, InnovationQuarter
- Advisors
- &CREW, DLA Piper, EY, DGMR, Van Rossum, Adviesbureau DWA, Jacobs Engineering Group Incorporation, Mees Ruimte & Milieu, TAUW, LAP Landscape & Urban Design, Van den Herik-Sliedrecht, Antea Group Nederland, CRUX Engineering BV, Goudappel, 4cast, DTV, BonoTraffics, Knijnenburg-Zwirs, Sweco, Bats & Birds, Vollebregt-Barten Onroerende Zaken Glastuinbouw, Crevasse advies, BarentsKrans


